DK376986A - Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf - Google Patents

Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK376986A
DK376986A DK376986A DK376986A DK376986A DK 376986 A DK376986 A DK 376986A DK 376986 A DK376986 A DK 376986A DK 376986 A DK376986 A DK 376986A DK 376986 A DK376986 A DK 376986A
Authority
DK
Denmark
Prior art keywords
tert
procedures
preparing
butylphenol compounds
butylphenol
Prior art date
Application number
DK376986A
Other languages
English (en)
Other versions
DK376986D0 (da
DK169324B1 (da
Inventor
Jill Ann Panetta
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK376986D0 publication Critical patent/DK376986D0/da
Publication of DK376986A publication Critical patent/DK376986A/da
Application granted granted Critical
Publication of DK169324B1 publication Critical patent/DK169324B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK376986A 1985-08-09 1986-08-07 Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne DK169324B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76416085A 1985-08-09 1985-08-09
US76416085 1985-08-09
US86948886A 1986-06-02 1986-06-02
US86948886 1986-06-02

Publications (3)

Publication Number Publication Date
DK376986D0 DK376986D0 (da) 1986-08-07
DK376986A true DK376986A (da) 1987-02-10
DK169324B1 DK169324B1 (da) 1994-10-10

Family

ID=27117408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK376986A DK169324B1 (da) 1985-08-09 1986-08-07 Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne

Country Status (24)

Country Link
EP (1) EP0211670B1 (da)
JP (1) JPH0625182B2 (da)
KR (1) KR870000889B1 (da)
CN (1) CN1014891B (da)
AR (1) AR243173A1 (da)
AU (1) AU590312B2 (da)
CA (1) CA1285572C (da)
CY (1) CY1619A (da)
DE (1) DE3670951D1 (da)
DK (1) DK169324B1 (da)
ES (1) ES2001075A6 (da)
GR (1) GR862081B (da)
HK (1) HK94791A (da)
HU (1) HU196192B (da)
IE (1) IE58718B1 (da)
IL (1) IL79648A (da)
LV (1) LV10866B (da)
MX (1) MX9203108A (da)
MY (1) MY102365A (da)
NZ (1) NZ217126A (da)
PH (1) PH24517A (da)
PT (1) PT83152B (da)
SG (1) SG80391G (da)
SU (1) SU1516012A3 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US4897406A (en) * 1987-11-13 1990-01-30 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
US5306822A (en) * 1988-05-25 1994-04-26 Warner-Lambert Company Arylmethylenyl derivatives of oxazolidinone
US5208250A (en) * 1988-05-25 1993-05-04 Warner-Lambert Company Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
ES2088965T3 (es) * 1989-04-07 1996-10-01 Lilly Co Eli Derivados de rodanina aril-sustituidos.
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
IL108962A (en) * 1989-12-21 1996-12-05 Lilly Co Eli Use of hydroxybenzyl substituted sulfur containing heterocyclic derivatives a process for their preparation and pharmaceutical compositions containing them
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0526598B1 (en) * 1990-04-27 1996-12-18 Orion-Yhtymà„ Oy New pharmacologically active catechol derivatives
ATE157355T1 (de) * 1991-01-21 1997-09-15 Shionogi & Co 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
US5143929A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
ATE135697T1 (de) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivate
ATE196464T1 (de) * 1993-06-23 2000-10-15 Chugai Pharmaceutical Co Ltd Benzol-derivate, verwendbar für ischämische erkrankungen
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5476865A (en) * 1994-07-06 1995-12-19 Eli Lilly And Company Methods of inhibiting bone loss
KR19980701588A (ko) * 1995-01-23 1998-05-15 피터 쥐. 스트링거 다발성 경화증의 치료 방법(Method for Treating Multiple Sclerosis)
DK0761657T3 (da) * 1995-09-07 2000-08-14 Lilly Co Eli Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
NZ332763A (en) * 1996-07-11 2000-07-28 Warner Lambert Co Treating and preventing neurodegenerative disorders by administering a thiazolidinone
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
DE202006018406U1 (de) 2006-12-05 2008-04-10 Seda S.P.A. Verpackung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038050B (de) * 1955-11-17 1958-09-04 Farmaceutici Italia S A Soc Verfahren zur Herstellung von 5-(3', 4'-Dioxybenzyliden)-Derivaten heterocyclischer Verbindungen
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd 3,5−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds

Also Published As

Publication number Publication date
EP0211670A2 (en) 1987-02-25
EP0211670B1 (en) 1990-05-09
DE3670951D1 (de) 1990-06-13
MY102365A (en) 1992-06-17
DK376986D0 (da) 1986-08-07
KR870000889B1 (ko) 1987-05-02
IE58718B1 (en) 1993-11-03
PH24517A (en) 1990-07-18
CN1014891B (zh) 1991-11-27
SU1516012A3 (ru) 1989-10-15
DK169324B1 (da) 1994-10-10
GR862081B (en) 1986-12-24
AU590312B2 (en) 1989-11-02
PT83152B (pt) 1989-03-30
MX9203108A (es) 1992-07-01
LV10866A (lv) 1995-10-20
IL79648A0 (en) 1986-11-30
NZ217126A (en) 1989-01-27
ES2001075A6 (es) 1988-04-16
CN86105036A (zh) 1987-02-04
HUT42765A (en) 1987-08-28
CY1619A (en) 1992-07-10
HK94791A (en) 1991-11-29
PT83152A (en) 1986-09-01
IL79648A (en) 1991-12-12
JPH0625182B2 (ja) 1994-04-06
LV10866B (en) 1996-04-20
SG80391G (en) 1991-11-15
AR243173A1 (es) 1993-07-30
EP0211670A3 (en) 1987-05-06
CA1285572C (en) 1991-07-02
HU196192B (en) 1988-10-28
JPS6242977A (ja) 1987-02-24
AU6097286A (en) 1987-02-12
KR870002109A (ko) 1987-03-30

Similar Documents

Publication Publication Date Title
DK376986D0 (da) Di-tert-butylphenol-forbindelser og fremgangsmaade til fremstilling heraf
DK313086A (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK491186A (da) Pyridonderivater og fremgangsmaade til fremstilling deraf
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
DK301886A (da) Furanon-derivater og fremgangsmaade til fremstilling heraf
DK437286A (da) 2,5-diaryl-tetrahydrothiophenforbindelse og fremgangsmaade til fremstilling deraf
DK335986D0 (da) Poly-4-aminopropyl-2-carboxamidoderivat og fremgangsmaade til fremstilling deraf
DK82686D0 (da) (1-benzyl-ethylendiamin)-platin(ii)-komplekser og fremgangsmaade til fremstilling heraf
DK315085A (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK4187D0 (da) Triazolylquinolin-derivater og fremgangsmaade til fremstilling deraf
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK401385D0 (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
NO863469D0 (no) Herbicid og fremgangsmaate for anvendelse derav.
DK317786D0 (da) Antibakterielt virksomme 7beta-heteroacylamino-4-chlor-cephalosporiner og fremgangsmaade til fremstilling heraf
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK165634C (da) Arylsulfonforbindelser og fremgangsmaader til fremstilling deraf
DK50686D0 (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
NO170761C (no) Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav
DK284184D0 (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf
DK230286A (da) Phosphinguldforbindelser og fremgangsmaade til fremstilling deraf
DK301785A (da) Tert-butyl-gamma-dimethylamino-beta-hydroxybutyrat og fremgangsmaadetil fremstilling deraf
DK319188A (da) Glycerolacetalaminoacylat og fremgangsmaade til fremstilling deraf
DK53887D0 (da) Emulgator og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK